Tehran, IRNA – The head of the Atomic Energy Organization of Iran (AEOI) says Iran has elevated the quantity of domestically produced radiopharmaceuticals from 50 within the yr 1402 (March 2023–March 2024) to 70 at current.
Speaking at a ceremony unveiling the most recent achievements of the Nuclear Science and Technology Research Institute, AEOI chief Mohammad Eslami mentioned that Iran had beforehand introduced the production of 50 radiopharmaceuticals, with one other 20 in varied levels of analysis and growth.
“In the year 1402, at this very location and at this same exhibition, we announced that we had 50 produced radiopharmaceuticals and that 20 more were in the research phase and at different stages,” he mentioned. “Today, I would like to inform you that we have reached 70 radiopharmaceuticals.”
Eslami described the AEOI as a scientific, research-oriented and industrial physique, saying it has turn out to be “a successful symbol of keeping the cycle of creativity and innovation alive,” a course of during which scientific information is transformed into merchandise within the shortest doable time.
The unveiling ceremony befell on the sidelines of the twenty sixth International Exhibition of Research, Technology and Tech-Market, throughout which an important achievements of the Nuclear Science and Technology Research Institute had been launched and unveiled.
The occasion was attended by Vice President Mohammad Reza Aref, Presidential Deputy for Science, Technology and Knowledge-Based Economy Hossein Afshin, and a quantity of senior officers from Iran’s nuclear business.
The newly unveiled achievements embrace the therapeutic radiopharmaceutical 177Lu-Alpha-MSH, the diagnostic radiopharmaceutical 68Ga-Alpha-MSH, an automatic system for producing radiopharmaceuticals used within the therapy of bone ache, and the launch of the National Nuclear Education Network.
These merchandise and initiatives are thought of among the many most vital technological achievements and strategic measures offered by Eslami on the exhibition.